Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04613609 · ClinicalTrials.gov registry record · Early Phase 1
Vaporized Nicotine and Autonomic Control
A Early Phase 1 study of Electronic Cigarette Use, sponsored by Michigan Technological University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT04613609 is a Early Phase 1 study of Electronic Cigarette Use that has completed, run by Michigan Technological University. The registered enrollment target is 16 participants, below the 212-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04613609, a Early Phase 1 study of Electronic Cigarette Use, has completed, sponsored by Michigan Technological University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
E-cigarettes are marketed as an alternative to smoking for those who want to decrease the health risks of tobacco. Tobacco cigarettes increase heart rate (HR) and arterial pressure, while reducing muscle sympathetic nerve activity (MSNA) through sympathetic baroreflex inhibition. The acute effects of e-cigarettes on arterial pressure and MSNA have not been reported: our purpose was to clarify this issue. Using a randomized crossover design, participants inhaled on a JUUL containing nicotine (59 mg/ml) and a similar placebo e-cigarette (0 mg/ml).
Conditions Studied
Interventions
- DEVICE Electronic Cigarette containing nicotine
- DEVICE Electronic Cigarette without nicotine
Study Locations (1)
Michigan
- Michigan Technological University - Houghton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2019-07-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04613609
The ClinicalTrials.gov registry entry for NCT04613609 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 212-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (92% lower). The listed sponsor is Michigan Technological University, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which Electronic Cigarette containing nicotine is the first listed.
NCT04613609 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04613609 about?
NCT04613609 is a clinical study titled "Vaporized Nicotine and Autonomic Control". E-cigarettes are marketed as an alternative to smoking for those who want to decrease the health risks of tobacco. Tobacco cigarettes increase heart rate (HR) and arterial pressure, while reducing muscle sympathetic nerve activity (MSNA) through sympathetic baroreflex inhibition. The acute effects o...
What is the current status of trial NCT04613609?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2018-04-01. Estimated completion is 2019-07-01.
What conditions does trial NCT04613609 study?
This clinical trial studies the following conditions: Electronic Cigarette Use.
What interventions are being tested in trial NCT04613609?
The interventions under investigation include: Electronic Cigarette containing nicotine (DEVICE), Electronic Cigarette without nicotine (DEVICE).
Who is sponsoring clinical trial NCT04613609?
This trial is sponsored by Michigan Technological University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04613609 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
RECRUITING · Early Phase 1
-
Effects of E-cigarette Use on Health
RECRUITING
-
Effects of Social Media Use on Young Adults' E-Cigarette Use
RECRUITING · NA
-
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
RECRUITING · NA
-
Effect of Menthol on ENDS Users' Addiction and Exposure
RECRUITING · NA
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.